[Skip to Navigation]
February 1956

Glycogen-Storage Disease: A Study on the Effect of Sodium/-Thyroxine and Glucagon

Author Affiliations

San Francisco
Dazianation Fellow (Dr. Koulischer) for Medical Research and from the PEndocrineMetabolic Laboratory, Department of Pediatrics, University of California Medical Center.

AMA Am J Dis Child. 1956;91(2):103-112. doi:10.1001/archpedi.1956.02060020105001

INTRODUCTION  Glycogen-storage disease is a congenital defect of carbohydrate metabolism characterized by deficient glycolysis and associated glycogen accumulation in various organs, particularly the liver. Secondary manifestations relate to the primary site of involvement. When the defect is principally in the liver, there is a propensity for hypoglycemia and exaggerated lipogenesis with secondary ketosis.The hepatic form of the disease, the first described,* is severest when manifest in the neonatal period.† Various other clinical types of the syndrome, not to be considered in this publication, have been described.‡Glycogen-storage disease appears to be familial, and the specific enzymatic defect or anomaly is presumably inherited as a simple recessive trait.§ This defect would appear to involve chiefly glucose-6-phosphatase. Substantial support for this thesis exists in the observations of Thannhauser and co-workers11 and Cori and associates,‖ who demonstrated low or absent glucose-6-phosphatase activity in liver preparations from several cases of classical von